Burkholderia pseudomallei clinical isolates are highly susceptible in vitro to cefiderocol, a novel siderophore cephalosporin
D. Burnard, G. Robertson, A. Henderson, C. Falconer, M. Bauer, K. Cottrell, I. Gassiep, R. Norton, D. L. Paterson, P. N. A. Harris
This study evaluates cefiderocol's in vitro activity against 271 Burkholderia pseudomallei isolates, finding high susceptibility with MIC90 values of 1 and 16 mg/L for primary and subsequent isolates, respectively.
bioRxiv · Mar 26, 2020Microbiology